Metronomic cyclophosphamide and methotrexate for breast cancer: Enhanced efficacy by adding dalteparin and low-dose prednisone?

被引：1
|
作者：
Buckman, Robert [1 ]
机构：
[1] Univ Toronto, Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2M9, Canada
来源：
BREAST | 2011年 / 20卷 / 05期
关键词：
D O I：
10.1016/j.breast.2011.06.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：483 / 484
页数：2
相关论文
共 50 条
  • [31] Hyponatremia Induced by Low-Dose Cyclophosphamide in two Patients with Breast Cancer
    Geng, Cuizhi
    Tang, Pengfei
    Zhang, Yan
    Gao, Wei
    BREAST JOURNAL, 2014, 20 (04): : 442 - 443
  • [32] Low-Dose Cyclophosphamide Associated with Hemorrhagic Cystitis in a Breast Cancer Patient
    Marshall, Ariela
    McGrath, Cindy
    Torigian, Drew
    Papanicolaou, Nicholas
    Lal, Priti
    Tweed, Carol Kaplan
    BREAST JOURNAL, 2012, 18 (03): : 272 - 275
  • [33] Erratum: Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
    O A Khan
    A D Blann
    M J Payne
    M R Middleton
    A S Protheroe
    D C Talbot
    M Taylor
    O Kirichek
    C Han
    M Patil
    A L Harris
    British Journal of Cancer, 2011, 105 : 1252 - 1252
  • [34] Combination Therapy With Rituximab and Low-Dose Cyclophosphamide and Prednisone in Membranous Nephropathy
    Vink, Coralien H.
    Wetzels, Jack F. M.
    van de Logt, Anne-Els
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (12): : 3439 - 3445
  • [35] Low-dose oral cyclophosphamide-methotrexate maintenance (CMM) for receptor-negative early breast cancer (BC).
    Colleoni, Marco
    Gray, Kathryn P.
    Gelber, Shari I.
    Lang, Istvan
    Thurlimann, Beat J. K.
    Gianni, Lorenzo
    Abdi, Ehtesham A.
    Price, Karen N.
    Gelber, Richard D.
    Viale, Giuseppe
    Coates, Alan S.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] EFFECTIVE LOW-DOSE INTERMITTENT CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL TREATMENT REGIMEN FOR METASTATIC BREAST-CANCER
    CREECH, RH
    CATALANO, RB
    MASTRANGELO, MJ
    ENGSTROM, PF
    CANCER, 1975, 35 (04) : 1101 - 1107
  • [37] Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated recurrent ovarian cancer.
    Sanchez-Munoz, A.
    Mendiola, C.
    Rodriguez, C. A.
    Perez-Ruiz, E.
    Jurado, J. M.
    Alonso-Carrion, L.
    Ghanem, I.
    Deelasco, G.
    Quero Blanco, C.
    Alba, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Bevacizumab plus Low-Dose Metronomic Oral Cyclophosphamide in Heavily Pretreated Patients with Recurrent Ovarian Cancer
    Sanchez-Munoz, Alfonso
    Mendiola, Cesar
    Perez-Ruiz, Elisabeth
    Rodriguez-Sanchez, Cesar A.
    Miguel Jurado, Jose
    Alonso-Carrion, Lorenzo
    Ghanem, Ismael
    de Velasco, Guillermo
    Quero-Blanco, Cristina
    Alba, Emilio
    ONCOLOGY, 2010, 79 (1-2) : 98 - 104
  • [39] Evaluation of low-dose metronomic (LDM) cyclophosphamide toxicity in cats with malignant neoplasia
    Leo, Chiara
    Stell, Anneliese
    Borrego, Juan
    Martinez de Merlo, Elena
    Ruess-Melzer, Katja
    Lara-Garcia, Ana
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2014, 16 (08) : 671 - 678
  • [40] Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice
    Emmenegger, Urban
    Shaked, Yuval
    Man, Shan
    Bocci, Guido
    Spasojevic, Ivan
    Francia, Giulio
    Kouri, Andrew
    Coke, Robert
    Cruz-Munoz, William
    Ludeman, Susan M.
    Colvin, O. Michael
    Kerbel, Robert S.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (08) : 2280 - 2289
12345